Show simple item record

dc.contributor.authorSánchez Aguinagalde, Oroitz
dc.contributor.authorSánchez Rexach, Eva
dc.contributor.authorPolo Arroyabe, Yurena
dc.contributor.authorLarrañaga Espartero, Aitor ORCID
dc.contributor.authorLejardi Meabebasterretxea, Ainhoa
dc.contributor.authorMeaurio Arrate, Emiliano ORCID
dc.contributor.authorSarasua Oiz, José Ramón ORCID
dc.date.accessioned2024-05-08T14:55:02Z
dc.date.available2024-05-08T14:55:02Z
dc.date.issued2024-04-13
dc.identifier.citationPolymers 16(8) : (2024) // Article ID 1088es_ES
dc.identifier.issn2073-4360
dc.identifier.urihttp://hdl.handle.net/10810/67734
dc.description.abstractThe obtention of amorphous solid dispersions (ASDs) of mycophenolic acid (MPA) in poly(ε-caprolactone) (PCL) is reported in this paper. An improvement in the bioavailability of the drug is possible thanks to the favorable specific interactions occurring in this system. Differential scanning calorimetry (DSC) was used to investigate the miscibility of PCL/MPA blends, measuring glass transition temperature (Tg) and analyzing melting point depression to obtain a negative interaction parameter, which indicates the development of favorable inter-association interactions. Fourier transform infrared spectroscopy (FTIR) was used to analyze the specific interaction occurring in the blends. Drug release measurements showed that at least 70% of the drug was released by the third day in vitro in all compositions. Finally, preliminary in vitro cell culture experiments showed a decreased number of cancerous cells over the scaffolds containing MPA, presumably arising from the anti-cancer activity attributable to MPA.es_ES
dc.description.sponsorshipThis research was funded by Spanish Ministry of Science and Innovation MICINN (PID2019-106236GB-I00) and the Basque Government Department of Education, Culture and Language Policy (IT1766-22).es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.relationinfo:eu-repo/grantAgreement/MICINN/PID2019-106236GB-I00es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/es/
dc.subjectpoly(ε-caprolactone) (PCL)es_ES
dc.subjectmycophenolic acid (MPA)es_ES
dc.subjectamorphous solid dispersions (ASDs)es_ES
dc.subjectmiscibilityes_ES
dc.subjectinteractionses_ES
dc.subjectdrug releasees_ES
dc.subjectcancer treatmentes_ES
dc.titlePhysicochemical Characterization and In Vitro Activity of Poly(ε-Caprolactone)/Mycophenolic Acid Amorphous Solid Dispersionses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.date.updated2024-04-27T14:05:59Z
dc.rights.holder© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/).es_ES
dc.relation.publisherversionhttps://www.mdpi.com/2073-4360/16/8/1088es_ES
dc.identifier.doi10.3390/polym16081088
dc.departamentoesIngeniería Minera y Metalúrgica y Ciencia de los Materiales
dc.departamentoeuMeatze eta metalurgia ingeniaritza materialen zientzia


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/).
Except where otherwise noted, this item's license is described as © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/).